BioNTech Announces Fourth Quarter and Full Year 2024 Financial Results and Corporate Update
Advanced oncology pipeline including more than 20 active Phase 2 and Phase 3 clinical trials with a strategic focus on two priority pan-tumor ...
BioNTech sees FY25 revenue EUR 1.7B-EUR 2.2B
BioNTech (BNTX) expects its revenues for the full 2025 financial year to be in the range of EUR 1.7B-EUR 2.2B and revenue phasing similar to ...
News-Medical.Net on MSN32m
MRNA vaccines, once a Trump boast, now face attacks from some in GOP
Researchers racing to develop bird flu vaccines for humans have turned to a cutting-edge technology that enabled the rapid development of lifesaving covid shots.
AllAfrica33m
Africa: U.S. Funding Cuts Imperil Search for HIV Vaccine
A groundbreaking project to study potential HIV vaccines in several African countries has been derailed by an abrupt cut in funding from the United States government. As a result, several promising ...
AlterNet on MSN53m
Republicans attack technology Trump touted as signature achievement of his first term
Researchers racing to develop bird flu vaccines for humans have turned to a cutting-edge technology that enabled the rapid ...